Your evaluation indicates that James has no markers for dependent use and isn't susceptible to a withdrawal syndrome. Your management of James may well include delivering brief intervention using the FRAMES solution in Desk 3, harm-minimisation education and learning using the STAYING Harmless proforma in Table four and referral to https://freebookmarkpost.com/story18122995/not-known-factual-statements-about-ghb-for-sale-in-europe